Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3758941, 7 pages
http://dx.doi.org/10.1155/2016/3758941
Research Article

High Efficient Expression, Purification, and Functional Characterization of Native Human Epidermal Growth Factor in Escherichia coli

1School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China
2Guangdong Province Key Laboratory of Fermentation and Enzyme Engineering, South China University of Technology, Guangzhou 510006, China

Received 25 July 2016; Accepted 5 September 2016

Academic Editor: Jiazhang Lian

Copyright © 2016 Yi Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. F. Fox, M. Wrann, P. Linsley et al., “Hormone-induced modification of EGF receptor proteolysis in the induction of EGF action,” Journal of Supramolecular Structure, vol. 12, no. 4, pp. 517–531, 1979. View at Publisher · View at Google Scholar
  2. S. Cohen and G. Carpenter, “Human epidermal growth factor: isolation and chemical and biological properties,” Proceedings of the National Academy of Sciences of the United States of America, vol. 72, no. 4, pp. 1317–1321, 1975. View at Publisher · View at Google Scholar · View at Scopus
  3. L. F. Soler, J. Cedano, E. Querol, and R. De Llorens, “Cloning, expression and purification of human epidermal growth factor using different expression systems,” Journal of Chromatography B, vol. 788, no. 1, pp. 113–123, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Oka, S. Sakamoto, K. Miyoshi et al., “Synthesis and secretion of human epidermal growth factor by Escherichia coli,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 21, pp. 7212–7216, 1985. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Sivakesava, Z. N. Xu, Y. H. Chen et al., “Production of excreted human epidermal growth factor (hEGF) by an efficient recombinant Escherichia coli system,” Process Biochemistry, vol. 34, no. 9, pp. 893–900, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. C. George-Nascimento, A. Gyenes, S. M. Halloran et al., “Characterization of recombinant human epidermal growth factor produced in yeast,” Biochemistry, vol. 27, no. 2, pp. 797–802, 1988. View at Publisher · View at Google Scholar · View at Scopus
  7. P. V. Hamsa, P. Kachroo, and B. B. Chattoo, “Production and secretion of biologically active human epidermal growth factor in Yarrowia lipolytica,” Current Genetics, vol. 33, no. 3, pp. 231–237, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-H. Heo, S. W. Hye, A. K. Hyun, S.-K. Rhee, and H. C. Bong, “Purification of recombinant human epidermal growth factor secreted from the methylotrophic yeast Hansenula polymorpha,” Protein Expression and Purification, vol. 24, no. 1, pp. 117–122, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Su, Y. Huang, Q. Zhou et al., “High-level expression and purification of human epidermal growth factor with SUMO fusion in Escherichia coli,” Protein and Peptide Letters, vol. 13, no. 8, pp. 785–792, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. T. R. Butt, S. C. Edavettal, J. P. Hall, and M. R. Mattern, “SUMO fusion technology for difficult-to-express proteins,” Protein Expression and Purification, vol. 43, no. 1, pp. 1–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. J. F. Li, J. Zhang, R. Song, J. X. Zhang, Y. Shen, and S. Q. Zhang, “Production of a cytotoxic cationic antibacterial peptide in Escherichia coli using SUMO fusion partner,” Applied Microbiology and Biotechnology, vol. 84, no. 2, pp. 383–388, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Elleuche and S. Pöggeler, “Inteins, valuable genetic elements in molecular biology and biotechnology,” Applied Microbiology and Biotechnology, vol. 87, no. 2, pp. 479–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Bastings, I. Baal, E. W. Meijer et al., “One-step refolding and purification of disulfide-containing proteins with a C-terminal MESNA thioester,” BMC-Biotechnology, vol. 8, article 76, 2008. View at Google Scholar
  14. M. R. Banki, T. U. Gerngross, and D. W. Wood, “Novel and economical purification of recombinant proteins: intein-mediated protein purification using in vivo polyhydroxybutyrate (PHB) matrix association,” Protein Science, vol. 14, no. 6, pp. 1387–1395, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Charalambous, M. Andreou, and P. A. Skourides, “Intein-mediated site-specific conjugation of Quantum Dots to proteins in vivo,” Journal of Nanobiotechnology, vol. 7, article 9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Zhang, K. Zhang, Y. Wan et al., “A pH-induced, intein-mediated expression and purification of recombinant human epidermal growth factor in Escherichia coli,” Biotechnology Progress, vol. 31, no. 3, pp. 758–764, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Esipov, V. N. Stepanenko, L. A. Chupova, U. A. Boyarskikh, M. L. Filipenko, and A. I. Miroshnikov, “Production of recombinant human epidermal growth factor using Ssp dnaB mini-intein system,” Protein Expression and Purification, vol. 61, no. 1, pp. 1–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Telenti, M. Southworth, F. Alcaide, S. Daugelat, W. R. Jacobs Jr., and F. B. Perler, “The Mycobacterium xenopi GyrA protein splicing element: characterization of a minimal intein,” Journal of Bacteriology, vol. 179, no. 20, pp. 6378–6382, 1997. View at Google Scholar · View at Scopus
  19. P. L. Starokadomskyy, O. V. Okunev, D. M. Irodov, and V. A. Kordium, “Utilization of protein splicing for purification of the human growth hormone,” Molecular Biology, vol. 42, no. 6, pp. 966–972, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. L. E. Smith, J. Yang, L. Goodman et al., “High yield expression and purification of recombinant human apolipoprotein A-II in Escherichia coli,” Journal of Lipid Research, vol. 53, no. 8, pp. 1708–1715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. D. Leonida and I. Kumar, “Wound healing and skin regeneration,” in Bionanomaterials for Skin Regeneration, pp. 17–25, Springer, 2016. View at Publisher · View at Google Scholar
  22. R. Chen, “Bacterial expression systems for recombinant protein production: E. coli and beyond,” Biotechnology Advances, vol. 30, no. 5, pp. 1102–1107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Kishi, T. Nakamura, Y. Nishio, H. Maegawa, and A. Kashiwagi, “Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation,” American Journal of Physiology—Endocrinology and Metabolism, vol. 284, no. 4, pp. E830–E840, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Khorasanizadeh, L. D. Peters, and H. Roder, “Evidence for a three-state model of protein folding from kinetic analysis of ubiquitin variants with altered core residues,” Nature Structural Biology, vol. 3, no. 2, pp. 193–205, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. M. P. Malakhov, M. R. Mattern, O. A. Malakhova, M. Drinker, S. D. Weeks, and T. R. Butt, “SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins,” Journal of Structural and Functional Genomics, vol. 5, no. 1-2, pp. 75–86, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Baneyx, “Recombinant protein expression in Escherichia coli,” Current Opinion in Biotechnology, vol. 10, no. 5, pp. 411–421, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Reverter and C. D. Lima, “A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex,” Structure, vol. 12, no. 8, pp. 1519–1531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. J. R. Sydor, M. Mariano, S. Sideris, and S. Nock, “Establishment of intein-mediated protein ligation under denaturing conditions: C-terminal labeling of a single-chain antibody for biochip screening,” Bioconjugate Chemistry, vol. 13, no. 4, pp. 707–712, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. T. C. Evans Jr. and M.-Q. Xu, “Intein-mediated protein ligation: harnessing nature's escape artists,” Biopolymers, vol. 51, no. 5, pp. 333–342, 1999. View at Google Scholar · View at Scopus
  30. Z. Sun, J. Chen, H. Yao et al., “Use of Ssp dnaB derived mini-intein as a fusion partner for production of recombinant human brain natriuretic peptide in Escherichia coli,” Protein Expression and Purification, vol. 43, no. 1, pp. 26–32, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Chong, F. B. Mersha, D. G. Comb et al., “Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing element,” Gene, vol. 192, no. 2, pp. 271–281, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Klabunde, S. Sharma, A. Telenti, W. R. Jacobs Jr., and J. C. Sacchettini, “Crystal structure of GyrA intein from Mycobacterium xenopi reveals structural basis of protein splicing,” Nature Structural Biology, vol. 5, no. 1, pp. 31–36, 1998. View at Publisher · View at Google Scholar · View at Scopus